<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221116056518N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-11-29</date_registration>
      <primary_sponsor>Rasht University of Medical Sciences</primary_sponsor>
      <public_title>Facial abrasions and amniotic membrane</public_title>
      <acronym>HAM</acronym>
      <scientific_title>The effect of traditional dressing and aminiotic dressing on facial abrasion repair: a randomized control trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>44</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/66878</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, in order to allocate patients to intervention and control groups, resticted randomization approach will be used in parallel with block randomization method. We will consider the blocks as a 4-size random. The allocation ratio of samples will be (1:1) and will be in two groups of control and intervention. Then, based on the obtained blocks and sequencing, allocation of dressings will be placed on patients in the control and intervention group. To generate random numbers, various packages in R software will be used.</study_design>
      <phase>4</phase>
      <hc_freetext>Facial abrasion.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: This study is a prospective cohort consisting of 24 patients with ulcers, which will be conducted by the Department of Oral and Maxillofacial Surgery (OMFS) of Porsina Hospital during the year 1401. The method of implantation used (conventional or amniotic membrane) will be explained in detail to each patient individually, including advantages, disadvantages, and written informed consent will be obtained from all. Patients will be randomly divided into 2 groups (12 people in each group). A group of people receiving standard or traditional treatment (control group). and another group of people whose wound will be covered with amniotic membrane and treated (intervention group). Permission for all stages of this study will be obtained from the university ethics committee. In the intervention group, after cleaning the wound surface with normal saline serum and separating foreign bodies (if any), washing with 0.9% normal saline and then biological dressing (amnion) will be done. Amnion biological surrogate (mother's pair) is used for non-diseased and healthy mothers after elective caesarean section in Al-Zahra Hospital. According to health protocols for mothers, blood samples are sent to the laboratory to check for HCV, HBS and HIV. The embryonic layers of the placenta are separated under the hood and then washed under sterile conditions with Ringer's solution, and the amnion layer is separated and transferred to sterile containers (4°C). In order to remove blood and other contaminants, it is washed four times with normal saline and then once with 0.25% sodium hypochlorite solution and washed again with normal saline. Then the samples are transferred to the refrigerator in sterile containers.To rule out bacterial contamination, routine cultures are performed from the stored membranes. Amniotic curtains should be prepared no later than 12 hours after delivery, and after freezing and drying, they can be stored for about a year. Regarding the placement of the amnion membrane, care must be taken to ensure that the lower layer, which has the ability to multiply, is placed on the wound and that the tissue is not placed on the wound from behind. Then dressing will be done for 2 weeks on days 4, 7 and 14. When the amniotic membrane is placed on the wound, it will stick to itself and there will be no need for stitches. Pieces of amniotic membrane measuring 1-2 x 3-5 cm can be selected depending on the size and extent of the wound.Patients will be examined by an OMFS specialist at intervals of 1 month, 2 months, and 6 months, and the thickness of the scars will be evaluated with the Vancouver scar scale (VSS). Also, the rating of itching from 0 (no itching) to 4 (severe itching) will be done by the same expert. Intervention 2: Control group: In this study, the control group will receive standard treatment. This treatment includes using gentamicin ointment or tetracycline for decontamination, sutures if necessary, and then covering wounds with wet-to-dry dressing in this method after one week, the dressing is removed and after pulling the sutures, the person will be prescribed anti-scar ointment.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is The data is not enough</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Rahman Hosseiny kariz omar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Namjo St, Velayat Hospital</address>
        <city>Rasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4193713194</zip>
        <telephone>+98 13 3336 8540</telephone>
        <email>S.rahman.hosseiny@gmail.com</email>
        <affiliation>Rasht University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Rahman Hosseiny kariz omar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Namjoo street</address>
        <city>Rasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4193713194</zip>
        <telephone>+98 21 7795 8432</telephone>
        <email>s.rahman.hosseiny@gmail.com</email>
        <affiliation>Rasht University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>... Emergency department admission less than 24 hours after the incident
Satisfaction with participating in the study
Ages between 18 and 60
Facial ulcers at least 15% of the surface of the skin on the patient's face</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>late referral
history of heart, kidney, diabetes and other metabolic organs (e.g. thyroid, pituitary, etc.)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>T14.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Superficial injury of unspecified body region</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: This study is a prospective cohort consisting of 24 patients with ulcers, which will be conducted by the Department of Oral and Maxillofacial Surgery (OMFS) of Porsina Hospital during the year 1401. The method of implantation used (conventional or amniotic membrane) will be explained in detail to each patient individually, including advantages, disadvantages, and written informed consent will be obtained from all. Patients will be randomly divided into 2 groups (12 people in each group). A group of people receiving standard or traditional treatment (control group). and another group of people whose wound will be covered with amniotic membrane and treated (intervention group). Permission for all stages of this study will be obtained from the university ethics committee. In the intervention group, after cleaning the wound surface with normal saline serum and separating foreign bodies (if any), washing with 0.9% normal saline and then biological dressing (amnion) will be done. Amnion biological surrogate (mother's pair) is used for non-diseased and healthy mothers after elective caesarean section in Al-Zahra Hospital. According to health protocols for mothers, blood samples are sent to the laboratory to check for HCV, HBS and HIV. The embryonic layers of the placenta are separated under the hood and then washed under sterile conditions with Ringer's solution, and the amnion layer is separated and transferred to sterile containers (4°C). In order to remove blood and other contaminants, it is washed four times with normal saline and then once with 0.25% sodium hypochlorite solution and washed again with normal saline. Then the samples are transferred to the refrigerator in sterile containers.To rule out bacterial contamination, routine cultures are performed from the stored membranes. Amniotic curtains should be prepared no later than 12 hours after delivery, and after freezing and drying, they can be stored for about a year. Regarding the placement of the amnion membrane, care must be taken to ensure that the lower layer, which has the ability to multiply, is placed on the wound and that the tissue is not placed on the wound from behind. Then dressing will be done for 2 weeks on days 4, 7 and 14. When the amniotic membrane is placed on the wound, it will stick to itself and there will be no need for stitches. Pieces of amniotic membrane measuring 1-2 x 3-5 cm can be selected depending on the size and extent of the wound.Patients will be examined by an OMFS specialist at intervals of 1 month, 2 months, and 6 months, and the thickness of the scars will be evaluated with the Vancouver scar scale (VSS). Also, the rating of itching from 0 (no itching) to 4 (severe itching) will be done by the same expert.</i_keyword>
      <i_keyword>Control group: In this study, the control group will receive standard treatment. This treatment includes using gentamicin ointment or tetracycline for decontamination, sutures if necessary, and then covering wounds with wet-to-dry dressing in this method after one week, the dressing is removed and after pulling the sutures, the person will be prescribed anti-scar ointment.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The intensity of itching. Timepoint: (days 4, 7, 14). Method of measurement: Itching ratings from 0 (no itching) to 4 (severe itching) will be done by the same specialist.</prim_outcome>
      <prim_outcome>Degree of pain. Timepoint: (days 4, 7, 14). Method of measurement: Pain Score on a scale of one to ten by patients.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Rasht University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-11-09</approval_date>
        <contact_name>Ethics committee of Guilan University of Medical Sciences</contact_name>
        <contact_address>namjoo street, rasht, guilan Rasht Guilan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
